Grifols is a leading global healthcare company. Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine enable millions of patients around the world to lead more productive lives. Since our founding in 1909, our ever-growing mastery of plasma, diagnostics and life sciences, backed by our ethical leadership and industry-leading quality ...
Grifols is also a leader in transfusion medicine, helping ensure the safety of the world’s blood supply. In addition, we provide biological materials, including plasma, for life-science research and further manufacturing, and the company has a comprehensive portfolio of tools, information and services that enable hospitals to efficiently ...
Spanish drugmaker Grifols SA is facing restrictions on its Canadian licence to collect blood products following the deaths of two patients who made plasma donations in the country. Health Canada, ...
The Globe and Mail: Government probes into the deaths of two plasma donors found no link to Grifols’ donation process
Federal and provincial health probes into the deaths of two people following plasma donations at for-profit Grifols collection centres in Winnipeg found no link between the donation process and the ...
Government probes into the deaths of two plasma donors found no link to Grifols’ donation process
The Globe and Mail: Health Canada imposes new conditions on Grifols after deaths of two people who donated plasma
Health Canada is imposing new terms and conditions on the licences of Grifols, Canada’s only major commercial collector of blood plasma, after two people died following donations in recent months. The ...